mountaineer study lead to the tucatinib/trastuzumab fda approval - in discussion w/ dr. bekaii-saab
Published 1 year ago • 225 plays • Length 17:40Download video MP4
Download video MP3
Similar videos
-
17:11
emerald lead to the elacestrant fda approval - oncbrothers in discussion w/ dr. virginia kaklamani
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
1:11
32 month follow-up of mountaineer: tucatinib and trastuzumab in her2 mcrc
-
4:46
mountaineer: tucatinib in combination with trastuzumab for her2-positive metastatic colorectal c...
-
13:38
core valve loading
-
40:15
thoracic outlet syndrome: diagnosis & treatment
-
17:52
how to fix heart valves with the tavr procedure | san diego health
-
0:56
mountaineer results: trastuzumab and tucatinib for her2 mcrc
-
20:52
colon cancer algorithm discussion with oncology brothers (rohit & rahul gosain) and dr. cathy eng
-
5:25
her2climb fda approval
-
2:23
mountaineer-02: tucatinib in previously treated her2 gastric cancer
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
3:56
dr. paul kurlansky breaks down the significance of breakthrough tavr study
-
3:27
minimalist approach to tavr
-
3:52
tavr, echo appropriateness and mobile stroke unit
-
1:50
what is tavr?
-
4:29
the corevalve™ evolut™ pro transcatheter aortic valve (tavr) system
-
1:50
rapides regional health talk - tavr process
-
11:38
progress report i - tímea lázár
-
5:58
duke escobar & bronya sandorffy (stroke & applied neuroscience center)
-
44:00
not so fast: why tavr may not be the holy grail (nabil munfakh, md)